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Serum Amyloid A (SAA3) Produced by Rabbit Synovial Fibroblasts Treated
with Phorbol Esters or Interleukin 1 Induces Synthesis
of Collagenase and Is Neutralized with Specific Antiserum
Teresa I. Mitchell,* Charles I. Coon,* and Constance E. Brinckerhoff*"
Departments of*Medicine and tBiochemistry, Dartmouth Medical School, Hanover, New Hampshire 03756
Abstract
We report that nucleic acid sequence analysis of a full-length
cDNA clone for a rabbit serum amyloid A (SAA)-like protein
has identified this protein as more closely related to SAA3 than
to SAA1. SAA3 induced collagenase synthesis in rabbit syno-
vial fibroblasts, and immune IgG raised against this SAA pro-
tein abrogated the induction. Using antisera to immunoprecipi-
tate biosynthetically labeled 3H-SAA and 3H-collagenase from
culture medium, we compared the levels of SAA and collage-
nase synthesized by cultures of rabbit fibroblasts at early pas-
sage (passages 3-6) with those synthesized by late passage
cells (passage 16). Comparatively high levels of both proteins
were produced constitutively by fibroblasts at low passage.
With increasing passage, levels of both proteins drop so that by
passage 16, constitutive production of SAA and collagenase
was only - 15-20% that of passage 3 cells. Cells at low pas-
sage could be readily stimulated with phorbol myristate acetate
(PMA) or interleukin 1 (IL-1) to synthesize increased amounts
of both SAA and collagenase. In passage 5 cells treated with
PMA, we detected increased SAA mRNA by 1.5 h and collage-
nase mRNA by 5 h. However, older passage cells were more
refractory to stimulation and required longer induction times.
We suggest that SAA3 may be expressed by fibroblasts at sites
of acute inflammation or injury, and that elevated levels of
SAA3 may signify "activated" fibroblasts which are already
producing increased amounts of collagenase constitutively and
which are predisposed to further stimulation. (J. Clin. Invest.
1991. 87:1177-1185.) Key words: metalloproteinase - gene ex-
pression * inflammation * rheumatoid arthritis * SAA
Introduction
The serum amyloid A (SAA)' proteins, of 14 kD (reviewed
in 1, 2) are precursors to the amyloid A (AA) protein, a major
constituent of the fibrous deposits in amyloidosis associated
with chronic inflammatory disorders, such as rheumatoid ar-
thritis and ankylosing spondylitis (3). SAA is an acute phase
reactant, synthesized principally by the liver in response to
stress or inflammation, and it is secreted and transported in the
plasma complexed with high density lipoprotein (1, 2). Its
function is unknown.
Received for publication 22 August 1990 and in revisedform 14 No-
vember 1990.
1. Abbreviation used in this paper: SAA, serum amyloid A.
In the mouse, SAA 1 and SAA2 are similar genes encoding
proteins which differ from each other at only nine of 103
amino acid positions (4). These genes are 95% homologous in
both coding and noncoding regions. A third gene, SAA3, is
only 70% homologous with SAA 1. In the human, two forms of
amyloid protein, SAA 1 and SAA2, are present in serum, with
SAA 1 being predominant (1, 2, 5-8). A third form has recently
been described and although it was designated GSAA 1 (9), it
appears to share more homology with mouse SAA3 than with
SAA1 (4).
Recently, we isolated an autocrine protein produced by
rabbit fibroblasts that induced the synthesis of collagenase in
these cells (10). Collagenase is the only enzyme active at neutral
pH that can initiate breakdown of the interstitial collagens, I,
II, and III, thus assigning it a major role in the normal model-
ing and remodeling ofthe extracellular matrix (wound healing,
uterine resorption) and in the destruction of connective tissue
in diseases states (rheumatoid and osteoarthritis, and tumor
invasion) (reviewed in 1 1). Amino acid sequencing of the 25
NH2-terminal residues of this autocrine protein identified it as
an SAA-like protein, M, 14 K (10).
In this paper, we continue our characterization of rabbit
fibroblast SAA as we begin to understand how this protein
induces collagenase synthesis. To this end, we have developed a
polyclonal antiserum to rabbit fibroblast SAA and showed that
this antiserum can neutralize the ability ofSAA to induce colla-
genase. We have isolated a cDNA clone and found that this
cDNA has greater homology to human and mouse SAA3 than
to SAA 1. Finally, we have studied the relationship between
SAA and collagenase synthesis in cells following the addition of
two inflammatory mediators, phorbol myristate acetate (PMA)
or IL- 1. We conclude that increased synthesis ofSAA3 may be
a step in a pathway leading to increased collagenase synthesis.
Methods
Cell culture. Rabbit synovial fibroblasts were derived from the knee
synovium of 5-wk-old New Zealand White rabbits (Millbrook Farms,
Amherst, MA) by digestion with bacterial collagenase (4 mg/ml;
Worthington Cooper Biomedical, Freehold, NJ) (10, 12). Monolayers
ofprimary cultures were grown to confluence in DMEM with 20% FCS
(Gibco, Grand Island, NY) with penicillin and streptomycin (Gibco).
At confluence, cells were passaged 1:2 with 0.25% trypsin (Gibco) in
10% FCS. For experiments, cells were washed three times in HBSS (5
min/wash) to remove traces of serum and then placed in serum-free
DMEM supplemented with 0.2% lactalbumin hydrolysate (LH). Un-
less noted otherwise, experiments were performed with cells between
passage 4 and 7.
Purification ofSAA protein, preparation ofpolyclonal antiserum,
and isolation ofIgG. SAA protein was purified from conditioned me-
dium as described previously (10, 12). Briefly, rabbit synovial fibro-
blasts were cultured in DMEM-LH with PMA (1o-8 M) for 48 h. Con-
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ditioned medium was harvested and SAA was isolated by isoelectric
focusing with a Rotofor apparatus (Bio-Rad Laboratories, Inc., Rich-
mond, CA), and material focusing at pI 5 or 8 was applied to a Beck-
man TSK HPLC gel filtration column in 20 mM phosphate buffer,
0.15 M NaCl, pH 7.5. SAA eluted in fractions corresponding to M,
< 15 K. In some experiments, SAA was further purified by SDS-PAGE
and elution of the protein band from the SDS gel.
For preparation of antiserum, purified SAA to be used as antigen
was isolated by SDS-PAGE and eluted from the gel. It was passed over
an AG 1 A8 ion retardation resin column (Bio-Rad Laboratories,
Inc.) to remove SDS (10) and then dialyzed so that it would at least
partially renature before being injected into a sheep. Before immuniza-
tion, a preimmune bleed was taken. For each injection, - 20 ug of
gel-purified SAA protein was mixed with complete Freund's adjuvant
and injected subcutaneously into the sheep. At 2-wk intervals, the
sheep was bled and booster injections were given for a total of ive
injections. Serum was stored at -20°C. IgG was isolated from both
preimmune and immune sera by an Immunopure Immobilized Pro-
tein G column (Pierce Chemical Co., Rockford, IL) according to the
manufacturer's protocol.
Western blot analysis and immunoprecipitation. For Western blots,
crude culture medium taken from PMA-stimulated rabbit fibroblasts
was partially purified by isoelectric focusing. 10Mg protein was applied
to each lane of a 7-15% SDS polyacrylamide gradient gel and electro-
blotted onto PVDF membrane (Immobilon; Millipore Corp., Free-
hold, NJ). After transfer, selected lanes were stained with Coomassie
brilliant blue to visualize total proteins. The remaining portion of the
blot was blocked for 1 h with 10% FCS in Tween 20 in Tris-buffered
saline (TTBS; 0.05% Tween 20; 50 mM Tris, pH 7.5; 150 mM NaCl).
a
The blot was then treated with preimmune orimmune serum, appropri-
ately diluted in TTBS, for 18 h at room temperature. Immunoreactiv-
ity was developed with the Vectastain ABC kit (Vector Laboratories,
Burlingame, CA): blots were placed in a solution ofbiotinylated second
antibody (rabbit anti-sheep immunoglobulin antiserum, 5 Mg/ml in
TTBS) for 30 min, washed three times in TTBS, and transferred to the
Vectastain ABC reagent (avidin and biotinylated horse radish peroxi-
dase substrate, 4-chloro-l-napthol with imidazole: 2 ml of a 3 mg/ml
solution in methanol added to 10 ml ofTTBS, with 50 Ml 2 M imidaz-
ole), and 5l of 30% H202. Color appeared in 3-15 min.
Immunoprecipitation of 3H-SAA and 3H-collagenase was per-
formed as we have described previously (10, 12). Cells were cultured in
medium containing 25 MCi/ml [3H1-leucine (143 Ci/mmol; Amersham
Corp., Chicago, IL) for 30 h, and an aliquot (e.g., 500 Mil) of medium
was added to a cocktail containing 0.5 M arginine hydrochloride, pH
8.0; 50mM Tris/HCI buffer, pH 8.6; 5 mM EDTA; 1% (vol/vol) Triton
X- 100, along with 20 Mul antiserum. After overnight incubation at room
temperature, immune complexes were isolated by addition of protein
A Sepharose beads (Sigma Chemical Co., St. Louis, MO). After wash-
ing (four times in 0.1 M Tris/HCl, pH 8.6, containing 250mM arginine
followed by one water wash), the antigen-antibody complexes were
dissociated by boiling in SDS-PAGE sample buffer and were loaded
onto a 7.5% polyacrylamide gel for collagenase and either a 12, 15, or a
7.5-15% gradient gel for SAA. Immunoprecipitated SAA and procolla-
genase were visualized by fluorography and were quantitated by excis-
ing and counting the protein bands. Radioactivity was extracted from
the gel by rehydrating appropriate slices ofthe gel in 0.5 ml H20 for 30
min. 1 ml Solvable (Dupont Co., Wilmington, DE) was then added and
the samples were incubated at 50°C for 3 h, followed by addition of20
Mr (k D)
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Figure 1. Western blot analysis of rabbit SAA protein. SAA in crude culture medium taken from PMA-stimulated rabbit fibroblasts was partially
purified by isoelectric focusing. After transfer to Immobilon, lanes were stained with Coomassie brilliant blue or reacted with preimmune or
immune serum. Blots were developed by addition of a biotinylated rabbit anti-sheep immunoglobulin antiserum, avidin, and biotinylated horse
radish peroxidase. Immunoreactive proteins were visualized by addition ofperoxidase substrate (4-chloro-1-naphthol with imidazole and H202
in 0.1 M Tris/NaCl). The Western blotting protocol and reagents were provided by Vectastain ABC Kit, Vector Laboratories, Burlingame, CA.
(a) Preimmune vs. immune serum in which 10 Mg protein focusing at pI 8 was applied to each lane of a 15% SDS polyacrylamide gel. (Lane 1)
Preimmune bleed, 1:5,000. (Lane 2) Total protein, stained with Coomassie brilliant blue. (Lane 3) Immune bleed No. 4, 1:5,000. (b) Dose/re-
sponse curve of purified rabbit SAA protein vs. immune serum in which varying amounts of SAA were loaded onto a 12% polyacrylamide gel,
and after transfer, reacted with immune bleed 6 at 1:10,000.
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ml Atomlight (Dupont Co.). After being vortexed and allowed to stand
overnight at room temperature, samples were counted in a liquid scin-
tillation spectrometer.
Total cellular protein in the monolayer was determined after re-
moval of the 3H-leucine-labeled culture medium. The wells were
washed twice with cold 5% trichloroacetic acid and the monolayer was
solubilized in 1 ml of 0.1 N NaOH. Protein was quantitated with the
Bradford reagent (Bio-Rad Laboratories, Inc.). The protein content of
a 35-mm-diam culture ranged typically from 90 to 120 gg and was not
affected by the experimental conditions (10).
Isolation and sequencing ofSAA cDNA clones. - 10I plaques of a
cDNA library in lambda gt 11 prepared from mRNA derived from
PMA-stimulated rabbit synovial fibroblasts (13) were screened with a
cDNA for human serum SAA 2 (6), labeled with [alpha32] P (3,000
Ci/mmol; Amersham Corp.) by the oligolabeling technique (14). Six
positive clones were purified through three rounds of plaque purifica-
tion and were subcloned into the Bluescript plasmid for di-deoxyse-
quencing with the aid ofa "helper phage" (Stratagene, Inc., San Diego,
CA) to produce single-stranded DNA (15).
Preparation ofmRNA and Northern blot analysis. RNA was har-
vested from confluent cultures of rabbit synovial fibroblasts in 150-
mm-diameter culture dishes using the guanidine HCl/cesium chloride
method (16). 10-20 ,g of total RNA was electrophoresed at 4VC in a
1% agarose gel containing 2.2 M formaldehyde, and then transferred to
Gene Screen Plus (New England Nuclear/Dupont, Boston, MA). Blots
were probed with [alpha 32[P]-cDNAs for rabbit SAA or collagenase
(17), the human c-jun cDNA (a gift from Dr. Michael Karin), labeled to
specific activities of 0.83 x 107 cpm/gg, 1.5 X 107 cpm/gg and 0.93
X 107 cpm/,ug, respectively, or with a probe for mouse ribosomal RNA
(18), a house-keeping gene used to control for variations in loading.
Between hybridizations, blots were stripped by boiling for 10 min in
0.1 x SSC with 1% SDS. After cooling, the solution was replaced and












Preparation ofpolyclonal antiserum vs. rabbit SAA protein. An-
tiserum to rabbit SAA was characterized by Western blot analy-
sis and by immunoprecipitation ofbiosynthetically labeled 3H-
SAA (Figs. 1 and 2). Western blot analysis with partially puri-
fied SAA protein revealed that only immune serum but not
preimmune serum reacted with SAA protein (Fig. 1 a). The
higher Mr band, not prominent in the lane showing a Coomas-
sie blue stain of total proteins, may be an aggregate of the par-
tially purified SAA because we do not see it in crude culture
medium (data not shown). Fig. 1 b shows that the serum, di-
luted 1:10,000, detected as little as 10 ng of SAA antigen, and
Fig. 2 demonstrates that antiserum dilutions of up to 1:500
immunoprecipitated biosynthetically labeled 3H-SAA protein
from crude culture medium, but that the preimmune serum
did not.
Neutralization ofSAA induction ofcollagenase by immune
IgG. To determine whether antibodies to SAA could neutralize
collagenase-inducing activity, we isolated IgG from nonim-
mune and immune serum. This was then mixed with SAA
protein, and after 2 h at 37°C, the mix was centrifuged and the
supernatant was tested for its ability to induce collagenase. Fig.
3 a shows that immune IgG at 1 mg/ml (bleed 8), but not
nonimmune IgG (bleed 1), partially neutralized the ability of
SAA to induce collagenase synthesis, and Fig. 3 b demonstrates
that this abrogation of collagenase induction depended on the
concentration ofimmune IgG.
Isolation and sequence analysis ofa cDNA clonefor rabbit
SAA. Using a cDNA probe for human SAA2 (6) to screen a
Figure 2. Immunoprecipitation of 3H-SAA rabbit protein from crude
culture medium. Monolayer cultures of rabbit synovial fibroblasts
were grown to confluence in 100-mm-diam culture dishes. The cells
were then washed and transferred to 10 ml leucine-free medium
containing PMA (10-8 M) and 3H-leucine (25 uCi/ml). After 30 h in-
cubation, aliquot portions of 750 ;lI culture medium were reacted
with preimmune or immune serum. Immunoprecipitated protein was
visualized with a 15% polyacrylamide gel and fluorography. (Lane
1) Preimmune serum diluted 1: 100. (Lanes 2-5) Immune serum bleed
No. 5 diluted 1: 100, 1:250, 1:500, 1: 1,000, respectively. (Lanes 6-9)
Immune serum bleed No. 6 diluted 1: 100, 1:250, 1:500, 1: 1,000, re-
spectively.
cDNA library prepared from mRNA taken from phorbol-
stimulated rabbit synovial fibroblasts (13), we isolated and se-
quenced six overlapping clones. Nucleic acid sequence analysis
of one full-length clone of 471 nucleotides revealed - 78%
homology in the protein coding region with human SAA 1 and
- 84% homology with human SAA3 (6, 9) (Fig. 4 a). The
cDNA encoded a protein of 122 amino acids, Mr 13,791, with a
deduced sequence that agrees almost completely with that ob-
tained by NH2-terminal sequencing of the purified rabbit pro-
tein (10). There are only two exceptions: a serine at position 1
ofthe secreted native protein vs. arginine at this position in the
deduced sequence, and a putative cysteine at position 18 in the
native protein vs. a tryptophan in the cDNA. The open reading
frame in the cDNA is preceded by a 5' untranslated region of44
nucleotides and is followed by a 3' untranslated region of 58
nucleotides.
Despite the high degree of overall conservation of our rab-
bitcDNA with both human SAA 1 (5) and SAA3 (9), the homol-
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Figure 3. Neutralization of SAA induction of collagenase by anti-SAA3 IgG. IgG was prepared from nonimmune (bleed 1) or immune serum
(bleed 6 or bleed 8) by standard methods, and was sterilized by filtration. To test for neutralization, the IgG was mixed with purified amyloid
protein (6 ,ug/ml) and incubated at 370C for 2 h. The mixture was then centrifuged for 5' at 12,000 g and the supernatant was added to
monolayer cultures of rabbit synovial fibroblasts in leucine-free medium. 'H-Leucine (25 ,uc/ml) was added, the cultures were incubated for 30
h at 370C, and the amount of 'H-collagenase synthesized was determined by immunoprecipitation with monospecific antibody to collagenase
and by 7.5% acrylamide gel and fluorography. 'H-Collagenase was quantitated by excising the protein bands and counting them by liquid scin-
tillation counting. Total cellular protein was measured and results are expressed as cpm/ 100 Ag. (a) Nonimmune vs. immune IgG. Bleed 1
(nonimmune) and bleed 8 (immune). Solid bar of SAA alone is a positive control; no IgG was added. (b) Dose/response curve of immune IgG
(bleed 6) in the presence of SAA.
ogy with human SAA3 is most apparent at the NH2-terminus,
where there are only four mismatches out of 25 residues, com-
pared to 12 of 25 when human SAA 1 is compared to the rabbit
protein (Fig. 4 b). These data suggest that SAA3 is the form of
SAA expressed by rabbit fibroblasts and that we have cloned
this protein. We also note that the deduced sequences for resi-
dues 32-45 is completely conserved, as has been reported for
all of the AA proteins examined thus far (20) (see Discussion
below).
Constitutive production ofSAA and collagenase and induc-
tion byPMA and IL-I. To begin to understand the relationship
between levels ofSAA and collagenase synthesis, we measured
the constitutive production ofboth proteins in cells at low pas-
sage (passage 3 or 6) and at higher passage (passage 16), and
then we compared the ability ofPMA and IL- 1 to stimulate the
synthesis of SAA and collagenase in these cells. A representa-
tive experiment demonstrating constitutive expression ofSAA
and collagenase production over a 72-h time period is pre-
sented in Fig. 5, and shows that young (passage 3) cells pro-
duced higher constitutive levels of SAA and collagenase,
whereas cells at passage 6 and 16 produced progressively lower
levels of both proteins. Compared to passage 3 cells, passage 6
cells secreted - 50% less SAA and collagenase and passage 16
cells secreted only 15-20%. However, for cells at any given
passage, the amount of SAA and collagenase remained fairly
constant over the 72-h culture period. It is important to note
that although the passage 3 cells have relatively high constitu-
tive levels of both SAA and collagenase, collagenase is still in-
ducible with PMA and IL- 1 (see below).
We next compared the ability of cells at passage 3, 6, or 16
to synthesize either SAA or collagenase in response to treat-
ment with either PMA or IL-1 (Fig. 6). Experiment 1 was
carried out with cells from the same rabbit, whereas experi-
ment 2 was performed with cells from different rabbits. Mea-
suring SAA production (Fig. 6 a), we found that in passage 3
cells SAA did not increase after 24 h of treatment with either
PMA or IL-1, perhaps because these young cells are already
synthesizing high levels of SAA constitutively. Further expo-
sure to either PMA or IL- 1 for as long as 72 h did not change
SAA levels (data not shown). When passage 6 cells were stimu-
lated with PMA or IL- 1, an increase in SAA was seen, and this
increase was maintained if the cells were stimulated for 72 h
(data not shown). In contrast, passage 16 cells had low constitu-
tive levels which were not increased by a 24-h treatment with
PMA or IL-1, and which increased hardly at all after 72 h in
culture.
When collagenase levels were measured in these cells, both
passage 3 and passage 6 cells responded well to phorbol or IL-l
(Fig. 6 b), and this increase was sustained over 72 h in culture
(data not shown). On the other hand, passage 16 cells at 24 h
responded weakly ifat all to either phorbol or IL- 1 and it is only
after a prolonged treatment of 72 h with PMA that an increase
in collagenase was seen. IL- 1 did not induce collagenase in the
higher passage cells.
It is essential to point out that these data illustrate trends,
rather than absolute values. Not every population of rabbit
fibroblasts at a given passage will express the identical amount
of SAA or collagenase. However, we can conclude that as pas-
sage number increases, constitutive production of both SAA
and collagenase decreases, the cells become more refractory to
stimulation, and only prolonged treatment with phorbol will
boost collagenase levels. These results have been confirmed
qualitatively with Western blots of nonradioactive culture me-
dium tested against antibodies to SAA and collagenase (data
not shown). Because similar results were seen regardless of
whether the cells were derived from a single rabbit or from
several rabbits, the differences observed are not due to differ-
ences among cells derived from different rabbits, but rather, are
passage-dependent.
Because higher levels of SAA are associated with young
cells which are already synthesizing elevated levels of collage-
nase and which can readily be stimulated further, we interpret

































































































































r GAGCCTGCTG GGACACTGCT GAAGTAG
200 Figure 4. Nucleic acid and protein sequence
analysis ofrabbit SAA protein. - IO' plaques
from a cDNA library prepared in lambda gt 11
with mRNA from PMA-stimulated rabbit
250 fibroblasts were screened with a cDNA clone
for human SAA2 (6). Six positive clones were
purified through three rounds of plaque purifi-
cation, and subcloned into the Bluescript plas-
3 0 0 mid for di-deoxysequencing with the aid ofa
"helper phage" (Stratagene, Inc.) to produce
single-stranded DNA. One clone was full-
length, and this sequence is shown and com-
pared with human SAA1 (5) and SAA3 (9), at
350 both the nucleic acid (a) and amino acid (b)
levels. In a the ATG translation start codon
and the TGA stop codon are bold-faced. Ho-
mologies between rabbit SAA3 and human
4 00 SAA3 are indicated by *, whereas homologies
between rabbit SAA3 and human SAA1 are
underlined. In b amino acid mismatches are
boxed out. r, rabbit amyloid; h3, human SAA3;
4 50 hl, human SAA .
these findings to suggest that (a) increased levels of SAA may
represent an "activated" cell which is already making some
collagenase and which is predisposed to further stimulation
with IL-1 or phorbol and (b) prolonged stimulation of older
cells may be necessary to first "activate" these cells so that they
can respond to inducers, perhaps by an SAA-independent
mechanism (see Discussion below).
Time coursefor the appearance ofSAA and collagenase. To
further understand the mechanism ofSAA induction ofcollage-
nase synthesis, we used cells at passage 5 to determine a time
course for increases in SAA and collagenase after addition of
phorbol. Because an increase in c-jun is associated with in-
creased collagenase production (21, 22), we also measured c-
jun mRNA. Phorbol was added to monolayers offibroblasts in
serum-free medium, and at intervals, selected cultures were
terminated and analyzed for SAA, c-jun, and collagenase
mRNAs (Fig. 7). Cells expressed some SAA mRNA constitu-
tively at time 0, and after addition of PMA, SAA mRNA in-
creased by 1.5 h. c-Jun mRNA increased by 3 h and was still
elevated at 8.5 h. Collagenase mRNA was first detected at 5 h.
When SAA and collagenase proteins were measured in the cul-
ture medium of these cells, SAA protein increased by 3 h and
collagenase protein was detected at 7 h (Fig. 8).
In a second experiment with cells at passage 11, we noted
that neither SAA nor c-jun mRNAs were detected at 2 h, but
both were increased at 5 h, followed by collagenase at 8 h (data
not shown). Thus, as in the previous experiment (Fig. 6), there
is a correlation between passage number and susceptibility to
induction: the older the passage number, the longer the induc-
tion period, and this longer induction is associated with a delay
in increased expression of c-jun. Although others have noted
an increase in c-jun before collagenase (21, 22), the time frame
of c-jun expression may vary, depending on the type of cells
used, the inducer, and the experimental conditions (21, 22). In
our experiments, the only variable was passage number, yet in
both experiments, our observations agree with those who have
also described an increase in c-jun levels before an increase in
collagenase (21, 22).
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Figure 5. Constitutive production ofSAA3 and collagenase by rabbit synovial fibroblasts. Rabbit synovial fibroblasts at passage 3, 6, or 16 were
grown to confluence in 35-mm-diam cluster dishes in DMEM with 10% FCS. The cells were then washed three times to remove traces of serum
and placed in 2 ml DMEM-LH. At 24 h, the medium was replaced with leucine-free medium and the cells were pulse-labeled for 4 h with
3H-leucine. Serum-free medium was replaced on the remaining cells, and after another 24 h selected cultures were pulsed-labeled. The remaining
cultures were again given fresh DMEM-LH; and after an additional 24 h (a total of 72 h), these cells were also pulse-labeled. Aliquot portions
ofthe culture medium were immunoprecipitated with monospecific antibody to rabbit SAA or collagenase, each diluted 1:100. The 3H-SAA and
3H-collagenase were visualized with a 7.5-15% gradient polyacrylamide gel and fluorography, and were quantitated by excising the bands of
protein and counting them. Total cellular protein of the monolayers was determined, and the data are expressed as cpm/ 100 ,gg.
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Figure 6. Induction ofSAA and collagenase by PMA and IL- i. This experiment was carried out with the same rabbit synovial fibroblasts de-
scribed in Fig. 5. At the start of the experiment, when selected cultures were washed and placed in 2 ml DMEM-LH, other cultures were treated
with PMA Io- M or Il- I (100 U/ml). At 24 h, the medium was replaced with leucine-free medium and the cells were pulse-labeled for 4 h with
3H-leucine. Serum-free medium, with or without PMA or IL- 1, was replaced in the remaining cultures, and after another 24 h selected cultures
were pulse-labeled. The remaining cultures were again given fresh DMEM-LH and PMA or IL- 1, and after an additional 24 h (a total of 72 h),
these cells were also pulsed. Aliquot portions of the culture medium were immunoprecipitated with monospecific antibody to rabbit SAA or
collagenase each diluted 1:100. The 3H-SAA and 3H-collagenase were visualized with 7.5-15% gradient polyacrylamide gel and fluorography,
and were quantitated by excising the bands of protein and counting them. Total cellular protein of the monolayers was determined, and the
results are expressed as cpm/I00 Ag. Experiment 1 was carried out with cells from a single rabbit, whereas experiment 2 was performed with cells
from different rabbits.
Discussion
In this paper, we confirm our previous observations that SAA is
produced by rabbit synovial fibroblasts and that this protein
acts in an autocrine fashion to increase collagenase synthesis in
these same cells. We also demonstrate that treatment with
PMA or IL- 1 increases SAA and that an immune IgG gener-
ated against this SAA protein neutralizes its collagenase induc-
ing activity. Further, by sequencing a full-length cDNA for this
protein, we have identified it as a rabbit form of SAA3.
As others have pointed out (20), the middle portion (resi-
dues 33-63) of the SAA proteins is widely conserved, and our
rabbit protein is no exception. The amino terminus ofthe mole-
cule shows more diversity and this has allowed us to compare
our rabbit SAA protein to other SAA proteins. The homology
between the first 25 residues of our rabbit protein and human
SAA3 is striking (Fig. 4 b). We and others (9) have noted con-
servation of 21 of the first 25 residues, or 84%. In contrast,
sequence comparison of these 25 residues with human SAA1
(5, 9) reveals conservation of 15 of the first 25 amino acids, or
only - 60%.
This type of sequence analysis has been helpful in identify-
ing which form of SAA is expressed extrahepatically. Expres-
sion of SAA mRNAs has been described in tissues of animals
injected with LPS or turpentine. These include lung, heart,
spleen, intestines, and kidney in mice (23), and ileum, lung,
and large intestine in rats (24), as well as numerous hamster
tissues (19). In both the hamster and rat, the SAA3 mRNA is
found only in extrahepatic tissues, leading the authors to con-
clude that SAA3 may be expressed abundantly at local nonhe-
patic sites of inflammation and tissue injury (19, 23, 24). Our
observations extend these findings by demonstrating that cul-
tured fibroblasts of nonhepatic origin express increased
amounts ofSAA3 in response to two additional inflammatory
mediators, PMA and IL- 1. Although we cannot be certain that
the rabbit SAA we have cloned is the equivalent of the SAA3
described for the rat and hamster, the evidence is suggestive.
Amino acid sequence comparison of the predicted rabbit and
hamster proteins reveals considerable homology between the
rabbit and hamster (19) proteins: 18 of the first 25 NH2-termi-
nal residues (or 72%) are conserved.
Our data also demonstrate a temporal relationship between
the increase in SAA levels and the rise in c-jun mRNA which is
associated with collagenase induction (21, 22). This temporal
relationship, coupled with the ability ofimmune IgG to SAA to
neutralize the collagenase-inducing ability ofthis protein, indi-
cate a causal role for SAA3 in a pathway leading to collagenase
induction. These observations allow us to hypothesize a model
in which SAA triggers an intracellular pathway that leads to an
increase in c-jun and, eventually, to an increase in collagenase
mRNA. Consistent with this model is the fact that induction of
collagenase requires an increase in collagenase gene transcrip-
tion (21, 22, 25-31) mediated, at least in part via an AP-l
element located in the promoter region of this gene (21, 22,
26-28, 31).
Presently, we do not understand the signal/transduction
pathway by which SAA induces collagenase. However, it is
intriguing to speculate that a receptor for SAA may be in-
volved. The complete conservation of residues 33-45 for the
SAA proteins has led to the suggestion that this portion of the
molecule might be involved in binding high-density lipopro-
tein complexes or cellular receptors (20). Although we do not
yet know if there are cellular receptors on fibroblasts for SAA
protein, we speculate that differences in the levels of cellular
receptors might contribute, at least in part, to differences in the
responsiveness of fibroblasts to stimuli such as IL- I and PMA.
Compared to older cells (passage 16), we noted that young
cells (passage 3) had higher constitutive levels ofSAA and re-
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Figure 7. Time course for induction of SAA, c-jun and collagenase
mRNAs. Rabbit synovial fibroblasts were grown to confluence in
1 50-mm-diam culture dishes, washed three times in HBSS to remove
traces ofserum and then placed in DMEM-LH and PMA (1o-8 M).
At selected times, RNA was harvested and analyzed by Northern blot
analysis by hybridization with alpha 32P-labeled cDNA probes for
rabbit SAA and collagenase and human c-jun. Ribosomal RNA,
measured with an alpha 32P-labeled cDNA probe for mouse ribosomal
gene, was used as a "housekeeping" gene to control for variations in
loading. mRNAs were detected by autoradiography; SAAmRNA: 6 h
exposure; c-jun, collagenase, and ribosomal mRNAs: 18-h exposure.
sponded more quickly to produce collagenase when treated
with PMA or IL- 1. This observation suggests that elevated lev-
els ofSAA, such as those seen in younger passage cells, may be
a marker for fibroblasts that can readily be stimulated to synthe-
size collagenase, either by an autocrine mechanism, directly, or
by the addition of exogenous stimuli, such as PMA and IL- 1.
The cells of older passage required prolonged exposure to in-
ducing agents to achieve collagenase levels equal to those of
younger cells, perhaps because these older cells must first be
"activated" before collagenase can be induced. However, be-
cause these older passage cells produced relatively low levels of
SAA even with prolonged stimulation by PMA or IL-1, it is
also possible that collagenase induction may occur through an
SAA-independent pathway. At the transcriptional level, both
fos-dependent (28-30) and fos-independent (30) pathways for
metalloproteinase induction have been reported, and it is possi-
ble that SAA-dependent and independent pathways may repre-
sent a cellular counterpart ofthe pathways leading to induction
of metalloproteinase synthesis.
It is significant that two inflammatory stimuli, phorbol es-
ters and IL-1, can induce SAA. These two compounds have
long been known to induce collagenase, a metalloproteinase
that is overexpressed in conjunction with the inflammation
seen in rheumatoid arthritis (3, 1 1). Conceivably, mediators
such as IL- could stimulate SAA3 expression in rheumatoid
synovium which could, in turn, induce collagenase and en-
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Figure 8. Time course for appearance ofSAA and collagenase pro-
teins. Serum-free culture medium was harvested from the cells de-
scribed in Fig. 8 and SAA and collagenase protein were detected by
Western blot analysis. Culture medium proteins were separated with
a 7.5 to 15% gradient polyacrylamide gel, blotted onto Immobilon.
Blots were reacted with polyclonal antisera to SAA and collagenase
diluted 1:30,000 and 1:10,000, respectively, and color was developed
as described in Methods. (a) SAA protein. (b) Collagenase protein.
have not yet identified this protein in human tissue, perhaps
because, as has been suggested, the mRNA has a short half-life
and/or because this protein is readily degraded (9, 32). Alterna-
tively, it is possible that SAA is not expressed in human rheu-
matoid synovial cells, and that 12 microglobulin plays a role.
Indeed, 12 microglobulin is also an autocrine inducer ofcollage-
nase (10) and its expression is increased by IL-l treatment of
human synovial tissue (22).
In conclusion, our data and those of other investigators
suggest that SAA3 is a distinct SAA gene product that is ex-
pressed at tissue-specific sites of local inflammation and injury
in response to stimuli such as IL-1 and phorbol esters. One
function of this locally produced SAA is the induction of me-
talloproteinases, potent modulators ofthe extracellular matrix.
Elevated production of SAA3 by fibroblasts may be a marker
for cells that are already synthesizing elevated levels ofmetallo-
proteinases constitutively and/or for cells that can readily be
stimulated to synthesize these enzymes. As such, SAA3 may
play a direct role mediating inflammatory responses.
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